Filing Details
- Accession Number:
- 0001225208-13-009142
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-02 17:03:56
- Reporting Period:
- 2013-03-31
- Filing Date:
- 2013-04-02
- Accepted Time:
- 2013-04-02 17:03:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1198959 | M James Cornelius | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Acquisiton | 2013-03-31 | 606 | $41.19 | 881,824 | No | 4 | A | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2013-04-01 | 10,000 | $41.09 | 871,824 | No | 4 | S | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2013-04-02 | 10,000 | $41.59 | 861,824 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares awarded to Mr. Cornelius for service as the Non-Executive Chairman.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $40.94 to $41.30, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.22 to $41.77, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.